scispace - formally typeset
R

Raymond S.M. Wong

Researcher at The Chinese University of Hong Kong

Publications -  198
Citations -  9479

Raymond S.M. Wong is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Internal medicine & Warfarin. The author has an hindex of 42, co-authored 180 publications receiving 7674 citations. Previous affiliations of Raymond S.M. Wong include Hong Kong Polytechnic University & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Use of convalescent plasma therapy in SARS patients in Hong Kong

TL;DR: In order to evaluate the efficacy of convalescent plasma therapy in the treatment of patients with severe acute respiratory syndrome (SARS), 80 SARS patients were given convalescence plasma at Prince of Wales Hospital, Hong Kong between 20 March and 26 May 2003.
Journal ArticleDOI

Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments.

TL;DR: A general approach for studying the major tissue contributors to the circulating DNA pool using genome-wide bisulfite sequencing of plasma DNA and deconvolution of the sequencing data with reference to methylation profiles of different tissues is developed.
Journal ArticleDOI

Haematological manifestations in patients with severe acute respiratory syndrome : retrospective analysis

TL;DR: Abnormal haematological variables were common among patients with SARS and the depletion of T lymphocyte subsets may be associated with disease activity.
Journal ArticleDOI

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Dominique Farge, +98 more
- 01 Oct 2019 - 
TL;DR: The 2019 International Initiative on Thrombosis and Cancer clinical practice guidelines, which are based on a systematic review of the literature published up to December, 2018, are presented along with a Grading of Recommendations Assessment Development and Evaluation scale methods.
Journal ArticleDOI

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.

TL;DR: Patients in the plasma group had a shorter hospital stay and lower mortality than the comparator group, and no immediate adverse effects were observed following plasma infusion, in a retrospective non-randomised study of severe acute respiratory syndrome.